Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
by on Friday, May 25th, 2012 | No Comments
Condition: Urothelial Carcinoma
Intervention: Drug: Valrubicin
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Endo Pharmaceuticals
Not yet recruiting – verified May 2012
Link: Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma